Related by context. Frequent words. (Click for all words.) 59 USFDA approval 58 Mipomersen 58 fusion inhibitor 58 application sNDA 57 FDA Accepts 57 Allovectin 7 R 57 Naproxcinod 57 NCEs 57 TRISENOX 57 Cethromycin 57 Investigational 57 Vfend 57 Pirfenidone 56 Pivotal Phase III 56 BLA submission 56 Laquinimod 56 Guanilib 56 voclosporin 56 Octreotide 56 Clevudine 56 Drug Application 56 Microspheres 56 Azilect ® 56 VALSTAR 55 ANDAs 55 Drug Candidate 55 StemEx 55 Thrombin 55 Phase III Clinical Trial 55 Preclinical Data 55 Ferumoxytol 55 SCHWARZ PHARMA 55 Eltrombopag 55 liprotamase 55 Urocidin 55 integrase inhibitor 55 elotuzumab 55 ONTAK 55 Panzem R 55 Orphan Drug Status 55 Diamyd ® 55 therapeutic monoclonal antibodies 55 Numax 55 Tyvaso 55 zileuton 55 Torisel 55 Pennsaid R 55 ELND# 55 ATryn ® 55 New Chemical Entities 55 Influenza Vaccine 55 orphan designation 55 Idera Pharmaceuticals 55 Monoclonal Antibody 55 Cladribine 55 Act PDUFA date 55 pediatric exclusivity 55 Vitaros 55 Privigen 54 Crofelemer 54 Alemtuzumab 54 LIVALO 54 MONOVISC 54 Generic Version 54 Oral Solution 54 Stressgen 54 Amrubicin 54 REPLAGAL 54 Arixtra 54 ALTANA Pharma 54 Pivotal Phase 54 Factive 54 Lenalidomide 54 ezogabine 54 Afluria 54 RNAi Therapeutics 54 Dasatinib 54 dalbavancin 54 TYGACIL 54 Small Molecule 54 Biologics License Application BLA 54 Rebif ® 54 Alvesco 54 interferon beta 1b 54 KNS # 54 Scancell 54 Traficet EN 54 Neurodex 54 GSK# [001] 54 Angiox 54 nanoviricides 53 Bayer Schering 53 SERMs 53 Topiramate 53 outlicensing 53 sBLA 53 Natalizumab 53 Protalix BioTherapeutics 53 Photocure 53 Thymoglobulin 53 Extended Release Tablets